CMS uses the NCD process to determine if its coverage is reasonable or needs to be adjusted. The governing body will not review all 32 topics, and approximately 10 are chosen each year, according to the report.
A review for a topic results in a referral to the Medicare Evidence Development & Coverage Advisory Committee for an assessment. A draft decision and comment period follows.
More Articles on Anesthesia:
FDA Accepts Merck Sugammadex Sodium Injection New Drug Application
CMS Updates Locale Specific Anesthesia Conversion Rate
Novitas Expected to Revise Anesthesia Coverage Limits
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
